⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
Moderna Named a Top Employer by Science for Eleventh Consecutive Year
accessnewswire.com
MRNA
Moderna to Host Investor Event - Analyst Day
accessnewswire.com
MRNA
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
accessnewswire.com
MRNA
Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
accessnewswire.com
MRNA
Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
accessnewswire.com
MRNA
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
accessnewswire.com
MRNA
Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
accessnewswire.com
MRNA
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
accessnewswire.com
MRNA
Moderna to Present at Upcoming Conferences in September 2025
accessnewswire.com
MRNA